BPA for inductively coupled plasma mass spectrometers (ICP-MS) with optional high-performance liquid chromatography (hplc) system
Active Awarded Last action
- Contract number
- 75F40122A00015
- Awardee
-
Agilent Technologies Inc. UEI SD9JZ9S7MEA6 Part of Agilent Technologies, Inc.
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Task orders
- 7 $3,474,519 obligated
Award facts
- Opportunity
-
- RFQ1571553 Solicitation number
- Combined order value
-
- $3,474,519 Current, with exercised options
- $3,492,265 Potential, with all options
- Last date to order 82% complete
- IDV ceiling 35% used
- $9,950,000.00
- Maximum order
- $9,950,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Food and Drug Administration established a Blanket Purchase Agreement with Agilent Technologies Inc. on September 19, 2022, against the GSA Multiple Award Schedule, with a $9.95 million ceiling for inductively coupled plasma mass spectrometers (ICP-MS) with optional high-performance liquid chromatography (HPLC) systems. The BPA extends through September 19, 2027.
Recent BPA calls reflect sustained FDA demand for analytical instrumentation. A $1.24 million call issued August 16, 2023, procured three single quad ICP-MS units, two triple quad ICP-MS/MS systems, and one HPLC system for delivery to Marshallton, Delaware. A $616.8 thousand call awarded September 29, 2022, covered three single quad ICP-MS and one HPLC system, also to Marshallton. On July 18, 2024, the FDA exercised a $349.2 thousand call for ICP-MS with optional HPLC to Alameda, California. More recent activity includes a $312.3 thousand call awarded September 11, 2025, for an ICP-QQQ system to support toxic-element method development at Marshallton. A $698.4 thousand call issued May 20, 2026, covered ICP-MS with optional HPLC for delivery to Irvine, California. On July 15, 2026, the FDA issued a $36.9 thousand call for one Agilent 1260 Infinity III HPLC system to Jamaica, New York.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75F40122A00015?
75F40122A00015 was awarded to Agilent Technologies Inc. by Food and Drug Administration (Department of Health and Human Services) on September 19, 2022.
How much is contract 75F40122A00015 worth?
Orders under 75F40122A00015 have obligated $3,474,519. Their combined potential value, with all options, is $3,492,265. 75F40122A00015's own ceiling is $9,950,000. A single order can be worth up to $9,950,000.
How many orders have been placed under contract 75F40122A00015?
7 orders have been placed under 75F40122A00015, the latest on July 15, 2026.
Who can order from contract 75F40122A00015?
75F40122A00015 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 75F40122A00015 under another contract?
Yes. 75F40122A00015 is a blanket purchase agreement under GS07F0564X, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75F40122A00015 competed?
The extent of competition for 75F40122A00015 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV